跳至主要内容
临床试验/NCT01051583
NCT01051583已完成2 期

Avastin as an Adjunct to Diode Laser Cyclophotoablation in the Treatment of Neovascular Glaucoma

Cairo University2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2006年1月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
16
试验地点
2
主要终点
Disappearance of iris neovessels

研究概览

简要总结

Assess the efficacy of Avastin as an adjunct to Diode Laser cyclophotocoagulation in the treatment of Neovascular Glaucoma.

详细描述

Design: Prospective, comparative interventional case series. Method: Patients were randomly assigned into Group A which were treated with Diode laser cyclophotocoagulation alone, whereas group B received intravitreal Avastin (One milligram = 0.04mL of 25 mg/mL) in conjunction with the Diode Laser. The preoperative data included etiology, mean age; follow up period, and a full ophthalmological examination with emphasis on mean IOP, iris neovascularization, pain and corneal edema.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
14 Years 至 72 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Neovascular absolute glaucoma
  • Painful blind eyes

排除标准

  • Neovascular glaucoma with useful vision or potential for useful vision

结局指标

主要结局

Disappearance of iris neovessels

时间窗: 2 weeks

次要结局

  • Intra ocular pressure(4 weeks)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验